Travere Therapeutics, Inc. (TVTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.21
Day's range
$29.31

Travere Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JUPITER TOPCO LLC 08/14/2026 11.32 M $643.30 M   100.00% 12.11%
BLACKROCK, INC. 08/07/2026 8.02 M $455.65 M   2.93% 8.58%
FMR LLC 08/13/2026 7.10 M $403.16 M   -35.30% 7.59%
BANK OF AMERICA CORP /DE/ 08/14/2026 4.57 M $259.53 M   239.63% 4.89%
STATE STREET CORP 08/07/2026 4.26 M $241.80 M   -14.19% 4.55%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.11 M $233.41 M   1.55% 4.40%
PERCEPTIVE ADVISORS LLC 08/14/2026 3.75 M $213.18 M   -9.41% 4.01%
MACQUARIE MANAGEMENT HOLDINGS, INC. 08/14/2026 2.81 M $159.78 M   -14.00% 3.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 2.57 M $145.97 M   162.98% 2.75%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.37 M $134.77 M   0.10% 2.54%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 2.18 M $123.79 M   47.44% 2.33%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 2.00 M $113.62 M   27.47% 2.14%
STEPHENS INVESTMENT MANAGEMENT GROUP LLC 07/29/2026 1.88 M $106.54 M   4.27% 2.01%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.83 M $104.14 M   -6.80% 1.96%
EMERALD ADVISERS, LLC 08/05/2026 1.60 M $90.95 M   2.81% 1.71%
ARMISTICE CAPITAL, LLC 08/14/2026 1.57 M $89.34 M   -67.89% 1.68%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.57 M $88.94 M   3.81% 1.67%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.54 M $87.58 M   -9.80% 1.65%
GOLDMAN SACHS GROUP INC 08/14/2026 1.54 M $87.22 M   -10.72% 1.64%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 1.53 M $87.09 M   49.97% 1.64%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.44 M $81.99 M   115.68% 1.54%
D. E. SHAW & CO., INC. 08/14/2026 1.44 M $81.83 M   72.19% 1.54%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 1.44 M $81.76 M   12.21% 1.54%
MARSHALL WACE, LLP 08/13/2026 1.33 M $75.74 M   646.74% 1.43%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.32 M $74.91 M   225.74% 1.41%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 1.16 M $65.73 M   957.72% 1.24%
BIOIMPACT CAPITAL LLC 08/14/2026 1.12 M $63.78 M   -0.94% 1.20%
NUVEEN, LLC 08/11/2026 1.05 M $59.91 M   12.37% 1.13%
EMERALD MUTUAL FUND ADVISERS TRUST 08/05/2026 1.03 M $58.63 M   9.21% 1.10%
JANE STREET GROUP, LLC 08/14/2026 938.70 K $53.33 M   210.54% 1.00%
NORTHERN TRUST CORP 08/13/2026 875.01 K $49.71 M   11.98% 0.94%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 827.28 K $47.00 M   4.61% 0.89%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 827.28 K $47.00 M   100.00% 0.89%
EVERSEPT PARTNERS, LP 08/14/2026 798.97 K $45.39 M   47.25% 0.85%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 661.82 K $37.60 M   8.03% 0.71%
ENSIGN PEAK ADVISORS, INC 08/14/2026 591.82 K $33.62 M   -17.31% 0.63%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 581.39 K $33.03 M   11.68% 0.62%
FIERA CAPITAL CORP 08/07/2026 517.00 K $29.37 M   -42.61% 0.55%
ARMISTICE CAPITAL, LLC 08/14/2026 500.00 K $28.41 M   100.00% 0.53%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 490.72 K $27.88 M   -17.23% 0.53%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 478.86 K $27.20 M   100.00% 0.51%
UBS GROUP AG 08/13/2026 473.46 K $26.90 M   -44.74% 0.51%
LOOMIS SAYLES & CO L P 08/14/2026 470.91 K $26.75 M   56.21% 0.50%
LEGAL & GENERAL GROUP PLC 08/14/2026 470.40 K $26.72 M   4.29% 0.50%
CANDRIAM S.C.A. 08/13/2026 470.27 K $26.69 M   27.10% 0.50%
INVESCO LTD. 08/14/2026 459.32 K $26.09 M   -12.30% 0.49%
GRAHAM CAPITAL MANAGEMENT, L.P. 08/14/2026 446.70 K $25.38 M   100.00% 0.48%
MORGAN STANLEY 08/13/2026 429.25 K $24.39 M   42.30% 0.46%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 427.31 K $24.28 M   5,290.50% 0.46%
GW&K INVESTMENT MANAGEMENT, LLC 08/12/2026 404.21 K $22.96 M   187.78% 0.43%

Travere Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 388 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:

Jupiter Topco LLC: 11.32 M

BlackRock, Inc.: 8.02 M

FMR LLC: 7.1 M

BANK OF AMERICA CORP /DE/: 4.57 M

STATE STREET CORP: 4.26 M

VANGUARD CAPITAL MANAGEMENT LLC: 4.11 M

113.51% of Travere Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 136.83 M shares in the last 24 months. This purchase volume represents approximately $3.97 B in transactions.